SYNTIS BIO REPORTS POSITIVE INITIAL PHASE 1/1B SINGLE ASCENDING DOSE DATA FOR SYNT-101, SUPPORTING ITS NOVEL APPROACH TO OBESITY TREATMENT

Reuters · 2d ago

Please log in to view news